3.1 Mortality (all‐cause): trials of participants taking a mean of ≥ 10 different medications versus trials of participants taking a mean of < 10 different medications |
15 |
|
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.83, 1.03] |
3.1.1 Study population taking a mean of ≥ 10 different medications |
6 |
|
Risk Ratio (IV, Random, 95% CI) |
0.96 [0.82, 1.11] |
3.1.2 Study population taking a mean of < 10 different medications |
9 |
|
Risk Ratio (IV, Random, 95% CI) |
0.91 [0.77, 1.08] |
3.2 Hospital readmissions (all‐cause): trials of participants taking a mean of ≥ 10 different medications versus trials of participants taking a mean of < 10 different medications |
14 |
|
Risk Ratio (IV, Random, 95% CI) |
0.94 [0.90, 0.99] |
3.2.1 Study population taking a mean of ≥ 10 different medications |
6 |
|
Risk Ratio (IV, Random, 95% CI) |
0.95 [0.89, 1.01] |
3.2.2 Study population taking a mean of < 10 different medications |
8 |
|
Risk Ratio (IV, Random, 95% CI) |
0.94 [0.87, 1.01] |
3.3 Hospital emergency department contacts (all‐cause): trials of participants taking a mean of ≥ 10 different medications versus trials of participants taking a mean of < 10 different medications |
8 |
3527 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.68, 1.03] |
3.3.1 Study population taking a mean of ≥ 10 different medications |
5 |
2948 |
Risk Ratio (M‐H, Random, 95% CI) |
0.97 [0.86, 1.10] |
3.3.2 Study population taking a mean of < 10 different medications |
3 |
579 |
Risk Ratio (M‐H, Random, 95% CI) |
0.59 [0.38, 0.94] |
3.4 Mortality (all‐cause): trials with criteria‐based medication review versus trials with non‐criteria‐based medication review |
18 |
|
Risk Ratio (IV, Random, 95% CI) |
0.96 [0.87, 1.05] |
3.4.1 Criteria‐based medication review |
6 |
|
Risk Ratio (IV, Random, 95% CI) |
0.97 [0.82, 1.15] |
3.4.2 Non‐criteria‐based medication review |
12 |
|
Risk Ratio (IV, Random, 95% CI) |
0.95 [0.84, 1.07] |
3.5 Hospital readmissions (all‐cause): trials with criteria‐based medication review versus trials with non‐criteria‐based medication review |
16 |
|
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.89, 0.98] |
3.5.1 Criteria‐based medication review |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
0.98 [0.91, 1.05] |
3.5.2 Non‐criteria‐based medication review |
11 |
|
Risk Ratio (IV, Random, 95% CI) |
0.91 [0.85, 0.96] |
3.6 Hospital emergency department contacts (all‐cause): trials with criteria‐based medication review versus trials with non‐criteria‐based medication review |
8 |
3527 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.68, 1.03] |
3.6.1 Criteria‐based medication review |
1 |
118 |
Risk Ratio (M‐H, Random, 95% CI) |
0.60 [0.15, 2.40] |
3.6.2 Non‐criteria‐based medication review |
7 |
3409 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.68, 1.04] |
3.7 Mortality (all‐cause): trials with low implementation rate versus trials with high implementation rate |
18 |
|
Risk Ratio (IV, Random, 95% CI) |
0.96 [0.87, 1.05] |
3.7.1 Low implementation rate |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
1.04 [0.85, 1.27] |
3.7.2 High implementation rate |
13 |
|
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.83, 1.04] |
3.8 Hospital readmissions (all‐cause): trials with low implementation rate versus trials with high implementation rate |
17 |
|
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.89, 0.98] |
3.8.1 Low implementation rate |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
0.97 [0.90, 1.05] |
3.8.2 High implementation rate |
12 |
|
Risk Ratio (IV, Random, 95% CI) |
0.91 [0.86, 0.96] |
3.9 Hospital emergency department contacts (all‐cause): trials with low implementation rate versus trials with high implementation rate |
8 |
3527 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.68, 1.03] |
3.9.1 Low implementation rate |
2 |
206 |
Risk Ratio (M‐H, Random, 95% CI) |
0.50 [0.17, 1.49] |
3.9.2 High implementation rate |
6 |
3321 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.83, 1.05] |
3.10 Mortality (all‐cause): trials with low risk of bias versus trials with high risk of bias |
18 |
|
Risk Ratio (IV, Random, 95% CI) |
0.96 [0.87, 1.05] |
3.10.1 Low risk of bias |
12 |
|
Risk Ratio (IV, Random, 95% CI) |
1.01 [0.90, 1.12] |
3.10.2 High risk of bias |
6 |
|
Risk Ratio (IV, Random, 95% CI) |
0.82 [0.68, 0.99] |
3.11 Hospital readmissions (all‐cause): trials with low risk of bias versus trials with high risk of bias |
16 |
|
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.89, 0.98] |
3.11.1 Low risk of bias |
11 |
|
Risk Ratio (IV, Random, 95% CI) |
0.95 [0.90, 1.00] |
3.11.2 High risk of bias |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
0.88 [0.79, 0.97] |
3.12 Hospital emergency department contacts (all‐cause): trials with low risk of bias versus trials with high risk of bias |
8 |
3527 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.68, 1.03] |
3.12.1 Low risk of bias |
5 |
3217 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.83, 1.06] |
3.12.2 High risk of bias |
3 |
310 |
Risk Ratio (M‐H, Random, 95% CI) |
0.49 [0.25, 0.96] |
3.13 Mortality (all‐cause): trials with extended medication reviews versus trials with basic medication reviews |
18 |
|
Risk Ratio (IV, Random, 95% CI) |
0.96 [0.87, 1.05] |
3.13.1 Extended medication review |
11 |
|
Risk Ratio (IV, Random, 95% CI) |
0.93 [0.82, 1.06] |
3.13.2 Basic medication review |
10 |
|
Risk Ratio (IV, Random, 95% CI) |
1.02 [0.87, 1.21] |
3.14 Hospital readmissions (all‐cause): trials with extended medication reviews versus trials with basic medication reviews |
17 |
|
Risk Ratio (IV, Random, 95% CI) |
0.96 [0.92, 1.01] |
3.14.1 Extended medication review |
11 |
|
Risk Ratio (IV, Random, 95% CI) |
0.94 [0.87, 1.02] |
3.14.2 Basic medication review |
9 |
|
Risk Ratio (IV, Random, 95% CI) |
0.99 [0.92, 1.07] |
3.15 Hospital emergency department contacts (all‐cause): trials with extended medication reviews versus trials with basic medication reviews |
8 |
3527 |
Risk Ratio (M‐H, Random, 95% CI) |
0.87 [0.74, 1.02] |
3.15.1 Extended medication review |
5 |
1703 |
Risk Ratio (M‐H, Random, 95% CI) |
0.78 [0.60, 1.01] |
3.15.2 Basic medication review |
5 |
1824 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.61, 1.15] |